December 5 2013 Contact: Liz Dowling, (415) 388-2794 Dowling & Dennis Public Relations E-mail:Liz@DowlingDennis.net CHICAGO–Novian Health, developer of Novilase® Breast Therapy, announced the company has received a Notice of Allowance for a new patent.The U.S. patent,Application No. 12/778,580,covers interstitial laser therapy in combination with interstitial brachytherapy treatment. The technology could make breast cancer treatment more […]
Novian Health Venture Capital Activity in 1Q 2013 for Breast Cancer Clinical Trials (18 April 2013)
Chicago area last in venture capital activity in 1Q Venture capital activity in the Chicago area slowed to a crawl in the first quarter of the year, according to data released Thursday by Dow Jones VentureSource. Chicago-area companies raised $20 million in eight deals in the quarter. This was a significant decrease from the first […]
Novian Health Closes $11 Million in Funding for Breast Cancer Clinical Trials (04 Feb 2013)
CHICAGO – Novian Health, developer of Novilase® Breast Therapy, announced today that it has successfully completed a funding round totaling $11 million. iNetworks, LLC (Pittsburgh, Pa) led the round of Series A Preferred share financing, which also included prior and new investors. Proceeds from the funding will primarily be used to conduct Novian’s multicenter clinical […]
